1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Leukemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Gleevec 1.2.3 Sprycel 1.2.4 Tasigna 1.2.5 Clolar 1.2.6 Others 1.3 Market by Application 1.3.1 Global Leukemia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Leukemia Therapeutics Market Perspective (2016-2027) 2.2 Leukemia Therapeutics Growth Trends by Regions 2.2.1 Leukemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Leukemia Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Leukemia Therapeutics Industry Dynamic 2.3.1 Leukemia Therapeutics Market Trends 2.3.2 Leukemia Therapeutics Market Drivers 2.3.3 Leukemia Therapeutics Market Challenges 2.3.4 Leukemia Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Leukemia Therapeutics Players by Revenue 3.1.1 Global Top Leukemia Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Leukemia Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Leukemia Therapeutics Revenue 3.4 Global Leukemia Therapeutics Market Concentration Ratio 3.4.1 Global Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Leukemia Therapeutics Revenue in 2020 3.5 Leukemia Therapeutics Key Players Head office and Area Served 3.6 Key Players Leukemia Therapeutics Product Solution and Service 3.7 Date of Enter into Leukemia Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Leukemia Therapeutics Breakdown Data by Type 4.1 Global Leukemia Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Leukemia Therapeutics Forecasted Market Size by Type (2022-2027) 5 Leukemia Therapeutics Breakdown Data by Application 5.1 Global Leukemia Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Leukemia Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Leukemia Therapeutics Market Size (2016-2027) 6.2 North America Leukemia Therapeutics Market Size by Type 6.2.1 North America Leukemia Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Leukemia Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Leukemia Therapeutics Market Size by Type (2016-2027) 6.3 North America Leukemia Therapeutics Market Size by Application 6.3.1 North America Leukemia Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Leukemia Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Leukemia Therapeutics Market Size by Application (2016-2027) 6.4 North America Leukemia Therapeutics Market Size by Country 6.4.1 North America Leukemia Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Leukemia Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Leukemia Therapeutics Market Size (2016-2027) 7.2 Europe Leukemia Therapeutics Market Size by Type 7.2.1 Europe Leukemia Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Leukemia Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Leukemia Therapeutics Market Size by Type (2016-2027) 7.3 Europe Leukemia Therapeutics Market Size by Application 7.3.1 Europe Leukemia Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Leukemia Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Leukemia Therapeutics Market Size by Application (2016-2027) 7.4 Europe Leukemia Therapeutics Market Size by Country 7.4.1 Europe Leukemia Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Leukemia Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Leukemia Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Leukemia Therapeutics Market Size by Type 8.2.1 Asia-Pacific Leukemia Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Leukemia Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Leukemia Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Leukemia Therapeutics Market Size by Application 8.3.1 Asia-Pacific Leukemia Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Leukemia Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Leukemia Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Leukemia Therapeutics Market Size by Region 8.4.1 Asia-Pacific Leukemia Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Leukemia Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Leukemia Therapeutics Market Size (2016-2027) 9.2 Latin America Leukemia Therapeutics Market Size by Type 9.2.1 Latin America Leukemia Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Leukemia Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Leukemia Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Leukemia Therapeutics Market Size by Application 9.3.1 Latin America Leukemia Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Leukemia Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Leukemia Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Leukemia Therapeutics Market Size by Country 9.4.1 Latin America Leukemia Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Leukemia Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Leukemia Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Leukemia Therapeutics Market Size by Type 10.2.1 Middle East & Africa Leukemia Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Leukemia Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Leukemia Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Leukemia Therapeutics Market Size by Application 10.3.1 Middle East & Africa Leukemia Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Leukemia Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Leukemia Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Leukemia Therapeutics Market Size by Country 10.4.1 Middle East & Africa Leukemia Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Leukemia Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Leukemia Therapeutics Introduction 11.1.4 Roche Revenue in Leukemia Therapeutics Business (2016-2021) 11.1.5 Roche Recent Development 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Company Details 11.2.2 GlaxoSmithKline Business Overview 11.2.3 GlaxoSmithKline Leukemia Therapeutics Introduction 11.2.4 GlaxoSmithKline Revenue in Leukemia Therapeutics Business (2016-2021) 11.2.5 GlaxoSmithKline Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Leukemia Therapeutics Introduction 11.3.4 Novartis Revenue in Leukemia Therapeutics Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Details 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Leukemia Therapeutics Introduction 11.4.4 Bristol-Myers Squibb Revenue in Leukemia Therapeutics Business (2016-2021) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Eisai 11.5.1 Eisai Company Details 11.5.2 Eisai Business Overview 11.5.3 Eisai Leukemia Therapeutics Introduction 11.5.4 Eisai Revenue in Leukemia Therapeutics Business (2016-2021) 11.5.5 Eisai Recent Development 11.6 Biogen Idec 11.6.1 Biogen Idec Company Details 11.6.2 Biogen Idec Business Overview 11.6.3 Biogen Idec Leukemia Therapeutics Introduction 11.6.4 Biogen Idec Revenue in Leukemia Therapeutics Business (2016-2021) 11.6.5 Biogen Idec Recent Development 11.7 ERYtech Pharma 11.7.1 ERYtech Pharma Company Details 11.7.2 ERYtech Pharma Business Overview 11.7.3 ERYtech Pharma Leukemia Therapeutics Introduction 11.7.4 ERYtech Pharma Revenue in Leukemia Therapeutics Business (2016-2021) 11.7.5 ERYtech Pharma Recent Development 11.8 Celgene 11.8.1 Celgene Company Details 11.8.2 Celgene Business Overview 11.8.3 Celgene Leukemia Therapeutics Introduction 11.8.4 Celgene Revenue in Leukemia Therapeutics Business (2016-2021) 11.8.5 Celgene Recent Development 11.9 Genmab 11.9.1 Genmab Company Details 11.9.2 Genmab Business Overview 11.9.3 Genmab Leukemia Therapeutics Introduction 11.9.4 Genmab Revenue in Leukemia Therapeutics Business (2016-2021) 11.9.5 Genmab Recent Development 11.10 Cephalon 11.10.1 Cephalon Company Details 11.10.2 Cephalon Business Overview 11.10.3 Cephalon Leukemia Therapeutics Introduction 11.10.4 Cephalon Revenue in Leukemia Therapeutics Business (2016-2021) 11.10.5 Cephalon Recent Development 11.11 Clavis Pharma 11.11.1 Clavis Pharma Company Details 11.11.2 Clavis Pharma Business Overview 11.11.3 Clavis Pharma Leukemia Therapeutics Introduction 11.11.4 Clavis Pharma Revenue in Leukemia Therapeutics Business (2016-2021) 11.11.5 Clavis Pharma Recent Development 11.12 Pfizer 11.12.1 Pfizer Company Details 11.12.2 Pfizer Business Overview 11.12.3 Pfizer Leukemia Therapeutics Introduction 11.12.4 Pfizer Revenue in Leukemia Therapeutics Business (2016-2021) 11.12.5 Pfizer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Gleevec Table 3. Key Players of Sprycel Table 4. Key Players of Tasigna Table 5. Key Players of Clolar Table 6. Key Players of Others Table 7. Global Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Leukemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Leukemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Leukemia Therapeutics Market Share by Regions (2016-2021) Table 11. Global Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Leukemia Therapeutics Market Share by Regions (2022-2027) Table 13. Leukemia Therapeutics Market Trends Table 14. Leukemia Therapeutics Market Drivers Table 15. Leukemia Therapeutics Market Challenges Table 16. Leukemia Therapeutics Market Restraints Table 17. Global Leukemia Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Leukemia Therapeutics Market Share by Players (2016-2021) Table 19. Global Top Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Therapeutics as of 2020) Table 20. Ranking of Global Top Leukemia Therapeutics Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Leukemia Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Leukemia Therapeutics Product Solution and Service Table 24. Date of Enter into Leukemia Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 27. Global Leukemia Therapeutics Revenue Market Share by Type (2016-2021) Table 28. Global Leukemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Leukemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Leukemia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Leukemia Therapeutics Revenue Market Share by Application (2016-2021) Table 32. Global Leukemia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Leukemia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 35. North America Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 37. North America Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Leukemia Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Leukemia Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 64. Roche Company Details Table 65. Roche Business Overview Table 66. Roche Leukemia Therapeutics Product Table 67. Roche Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 68. Roche Recent Development Table 69. GlaxoSmithKline Company Details Table 70. GlaxoSmithKline Business Overview Table 71. GlaxoSmithKline Leukemia Therapeutics Product Table 72. GlaxoSmithKline Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 73. GlaxoSmithKline Recent Development Table 74. Novartis Company Details Table 75. Novartis Business Overview Table 76. Novartis Leukemia Therapeutics Product Table 77. Novartis Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 78. Novartis Recent Development Table 79. Bristol-Myers Squibb Company Details Table 80. Bristol-Myers Squibb Business Overview Table 81. Bristol-Myers Squibb Leukemia Therapeutics Product Table 82. Bristol-Myers Squibb Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 83. Bristol-Myers Squibb Recent Development Table 84. Eisai Company Details Table 85. Eisai Business Overview Table 86. Eisai Leukemia Therapeutics Product Table 87. Eisai Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 88. Eisai Recent Development Table 89. Biogen Idec Company Details Table 90. Biogen Idec Business Overview Table 91. Biogen Idec Leukemia Therapeutics Product Table 92. Biogen Idec Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 93. Biogen Idec Recent Development Table 94. ERYtech Pharma Company Details Table 95. ERYtech Pharma Business Overview Table 96. ERYtech Pharma Leukemia Therapeutics Product Table 97. ERYtech Pharma Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 98. ERYtech Pharma Recent Development Table 99. Celgene Company Details Table 100. Celgene Business Overview Table 101. Celgene Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 102. Celgene Recent Development Table 103. Genmab Company Details Table 104. Genmab Business Overview Table 105. Genmab Leukemia Therapeutics Product Table 106. Genmab Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 107. Genmab Recent Development Table 108. Cephalon Company Details Table 109. Cephalon Business Overview Table 110. Cephalon Leukemia Therapeutics Product Table 111. Cephalon Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 112. Cephalon Recent Development Table 113. Clavis Pharma Company Details Table 114. Clavis Pharma Business Overview Table 115. Clavis Pharma Leukemia Therapeutics Product Table 116. Clavis Pharma Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 117. Clavis Pharma Recent Development Table 118. Pfizer Company Details Table 119. Pfizer Business Overview Table 120. Pfizer Leukemia Therapeutics Product Table 121. Pfizer Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 122. Pfizer Recent Development Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Global Leukemia Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Gleevec Features Figure 3. Sprycel Features Figure 4. Tasigna Features Figure 5. Clolar Features Figure 6. Others Features Figure 7. Global Leukemia Therapeutics Market Share by Application: 2020 VS 2027 Figure 8. Hospital Case Studies Figure 9. Clinic Case Studies Figure 10. Leukemia Therapeutics Report Years Considered Figure 11. Global Leukemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Leukemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Leukemia Therapeutics Market Share by Regions: 2020 VS 2027 Figure 14. Global Leukemia Therapeutics Market Share by Regions (2022-2027) Figure 15. Global Leukemia Therapeutics Market Share by Players in 2020 Figure 16. Global Top Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Therapeutics as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Leukemia Therapeutics Revenue in 2020 Figure 18. Global Leukemia Therapeutics Revenue Market Share by Type (2016-2021) Figure 19. Global Leukemia Therapeutics Revenue Market Share by Type (2022-2027) Figure 20. North America Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Leukemia Therapeutics Market Share by Type (2016-2027) Figure 22. North America Leukemia Therapeutics Market Share by Application (2016-2027) Figure 23. North America Leukemia Therapeutics Market Share by Country (2016-2027) Figure 24. United States Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Leukemia Therapeutics Market Share by Type (2016-2027) Figure 28. Europe Leukemia Therapeutics Market Share by Application (2016-2027) Figure 29. Europe Leukemia Therapeutics Market Share by Country (2016-2027) Figure 30. Germany Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Leukemia Therapeutics Market Share by Type (2016-2027) Figure 38. Asia-Pacific Leukemia Therapeutics Market Share by Application (2016-2027) Figure 39. Asia-Pacific Leukemia Therapeutics Market Share by Region (2016-2027) Figure 40. China Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Leukemia Therapeutics Market Share by Type (2016-2027) Figure 48. Latin America Leukemia Therapeutics Market Share by Application (2016-2027) Figure 49. Latin America Leukemia Therapeutics Market Share by Country (2016-2027) Figure 50. Mexico Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Leukemia Therapeutics Market Share by Type (2016-2027) Figure 54. Middle East & Africa Leukemia Therapeutics Market Share by Application (2016-2027) Figure 55. Middle East & Africa Leukemia Therapeutics Market Share by Country (2016-2027) Figure 56. Turkey Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Roche Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 60. GlaxoSmithKline Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 61. Novartis Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 63. Eisai Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 64. Biogen Idec Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 65. ERYtech Pharma Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 66. Celgene Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 67. Genmab Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 68. Cephalon Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 69. Clavis Pharma Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 70. Pfizer Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Roche GlaxoSmithKline Novartis Bristol-Myers Squibb Eisai Biogen Idec ERYtech Pharma Celgene Genmab Cephalon Clavis Pharma Pfizer